BlackRock Fund Advisors - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 29 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$117,000
-8.6%
67,554
+2.6%
0.00%
Q3 2016$128,000
+11.3%
65,846
-0.3%
0.00%
Q2 2016$115,000
+69.1%
66,072
+32.1%
0.00%
Q1 2016$68,000
-25.3%
50,011
-7.3%
0.00%
Q4 2015$91,000
-9.9%
53,975
+3.8%
0.00%
Q3 2015$101,000
-1.0%
52,014
+37.5%
0.00%
Q2 2015$102,00037,8340.00%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,641,804$7,454,0006.54%
COMMODORE CAPITAL LP 2,983,513$13,545,0005.40%
Foresite Capital Management IV, LLC 1,787,094$8,113,0000.97%
Avoro Capital Advisors LLC 10,300,000$46,762,0000.81%
Boxer Capital, LLC 4,000,000$18,160,0000.62%
Sio Capital Management, LLC 562,339$2,553,0000.52%
ACUTA CAPITAL PARTNERS, LLC 315,341$1,432,0000.52%
CM Management, LLC 150,000$681,0000.51%
APIS CAPITAL ADVISORS, LLC 120,000$545,0000.50%
Versant Venture Management, LLC 543,753$2,469,0000.48%
View complete list of CYMABAY THERAPEUTICS INC shareholders